259 related articles for article (PubMed ID: 27216039)
1. Inhibition of CaMKIV relieves streptozotocin-induced diabetic neuropathic pain through regulation of HMGB1.
Zhao X; Shen L; Xu L; Wang Z; Ma C; Huang Y
BMC Anesthesiol; 2016 May; 16(1):27. PubMed ID: 27216039
[TBL] [Abstract][Full Text] [Related]
2. The Different Dynamic Changes of Nerve Growth Factor in the Dorsal Horn and Dorsal Root Ganglion Leads to Hyperalgesia and Allodynia in Diabetic Neuropathic Pain.
Gao Z; Feng Y; Ju H
Pain Physician; 2017 May; 20(4):E551-E561. PubMed ID: 28535564
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a rat model of type II diabetic neuropathic pain.
Dang JK; Wu Y; Cao H; Meng B; Huang CC; Chen G; Li J; Song XJ; Lian QQ
Pain Med; 2014 Apr; 15(4):637-46. PubMed ID: 24716590
[TBL] [Abstract][Full Text] [Related]
4. Sigma 1 receptor mediated HMGB1 expression in spinal cord is involved in the development of diabetic neuropathic pain.
Wang X; Feng C; Qiao Y; Zhao X
Neurosci Lett; 2018 Mar; 668():164-168. PubMed ID: 29421543
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of phosphorylated calcium/calmodulin-dependent protein kinase IIα relieves streptozotocin-induced diabetic neuropathic pain through regulation of P2X3 receptor in dorsal root ganglia.
He XF; Kang YR; Fei XY; Chen LH; Li X; Ma YQ; Hu QQ; Qu SY; Wang HZ; Shao XM; Liu BY; Yi-Liang ; Du JY; Fang JQ; Jiang YL
Purinergic Signal; 2023 Mar; 19(1):99-111. PubMed ID: 34973115
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of p53 and Parkin Induce Mitochondrial Dysfunction and Leads to the Diabetic Neuropathic Pain.
Yamashita A; Matsuoka Y; Matsuda M; Kawai K; Sawa T; Amaya F
Neuroscience; 2019 Sep; 416():9-19. PubMed ID: 31377450
[TBL] [Abstract][Full Text] [Related]
7. Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages.
Zhang X; Wheeler D; Tang Y; Guo L; Shapiro RA; Ribar TJ; Means AR; Billiar TR; Angus DC; Rosengart MR
J Immunol; 2008 Oct; 181(7):5015-23. PubMed ID: 18802105
[TBL] [Abstract][Full Text] [Related]
8. Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain.
Allette YM; Due MR; Wilson SM; Feldman P; Ripsch MS; Khanna R; White FA
Brain Behav Immun; 2014 Nov; 42():169-77. PubMed ID: 25014009
[TBL] [Abstract][Full Text] [Related]
9. Persistent mechanical allodynia positively correlates with an increase in activated microglia and increased P-p38 mitogen-activated protein kinase activation in streptozotocin-induced diabetic rats.
Cheng KI; Wang HC; Chuang YT; Chou CW; Tu HP; Yu YC; Chang LL; Lai CS
Eur J Pain; 2014 Feb; 18(2):162-73. PubMed ID: 23868758
[TBL] [Abstract][Full Text] [Related]
10. Ca
Tomita S; Sekiguchi F; Kasanami Y; Naoe K; Tsubota M; Wake H; Nishibori M; Kawabata A
Eur J Pharmacol; 2020 Dec; 888():173587. PubMed ID: 32971090
[TBL] [Abstract][Full Text] [Related]
11. Diabetes-induced Neuropathic Mechanical Hyperalgesia Depends on P2X4 Receptor Activation in Dorsal Root Ganglia.
Teixeira JM; Dos Santos GG; Neves AF; Athie MCP; Bonet IJM; Nishijima CM; Farias FH; Figueiredo JG; Hernandez-Olmos V; Alshaibani S; Tambeli CH; Müller CE; Parada CA
Neuroscience; 2019 Feb; 398():158-170. PubMed ID: 30537520
[TBL] [Abstract][Full Text] [Related]
12. The upregulation of NLRP3 inflammasome in dorsal root ganglion by ten-eleven translocation methylcytosine dioxygenase 2 (TET2) contributed to diabetic neuropathic pain in mice.
Chen W; Wang X; Sun Q; Zhang Y; Liu J; Hu T; Wu W; Wei C; Liu M; Ding Y; Liu D; Chong Y; Wang P; Zhu H; Cui W; Zhang J; Li Q; Yang F
J Neuroinflammation; 2022 Dec; 19(1):302. PubMed ID: 36527131
[TBL] [Abstract][Full Text] [Related]
13. The implication of transient receptor potential canonical 6 in BDNF-induced mechanical allodynia in rat model of diabetic neuropathic pain.
Miao B; Yin Y; Mao G; Zhao B; Wu J; Shi H; Fei S
Life Sci; 2021 May; 273():119308. PubMed ID: 33667520
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of glutamatergic transmission in anterior cingulate cortex in the diabetic rats with neuropathic pain.
Li W; Wang P; Li H
Neurosci Lett; 2014 May; 568():29-34. PubMed ID: 24686190
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NONRATT021972 siRNA regulates neuropathic pain behaviors in type 2 diabetic rats through the P2X7 receptor in dorsal root ganglia.
Liu S; Zou L; Xie J; Xie W; Wen S; Xie Q; Gao Y; Li G; Zhang C; Xu C; Xu H; Wu B; Lv Q; Zhang X; Wang S; Xue Y; Liang S
Mol Brain; 2016 Apr; 9():44. PubMed ID: 27107575
[TBL] [Abstract][Full Text] [Related]
16. Pronociceptive changes in the activity of rostroventromedial medulla (RVM) pain modulatory cells in the streptozotocin-diabetic rat.
Silva M; Amorim D; Almeida A; Tavares I; Pinto-Ribeiro F; Morgado C
Brain Res Bull; 2013 Jul; 96():39-44. PubMed ID: 23644033
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-193a Downregulates HMGB1 to Alleviate Diabetic Neuropathic Pain in a Mouse Model.
Wu B; Guo Y; Chen Q; Xiong Q; Min S
Neuroimmunomodulation; 2019; 26(5):250-257. PubMed ID: 31665716
[TBL] [Abstract][Full Text] [Related]
18. The effects of intraganglionic injection of calcium/calmodulin-dependent protein kinase II inhibitors on pain-related behavior in diabetic neuropathy.
Jelicic Kadic A; Boric M; Kostic S; Sapunar D; Puljak L
Neuroscience; 2014 Jan; 256():302-8. PubMed ID: 24161721
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model.
Cruz Duarte P; St-Jacques B; Ma W
Exp Neurol; 2012 Apr; 234(2):466-81. PubMed ID: 22309829
[TBL] [Abstract][Full Text] [Related]
20. High Mobility Group Box1 Inhibitor Glycyrrhizic Acid Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats.
Zhang H; Zhang R; Chen J; Shi M; Li W; Zhang X
Kidney Blood Press Res; 2017; 42(5):894-904. PubMed ID: 29241180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
